The "real life" impact of adding bevacizumab to first-line treatment of metastatic colorectal cancer: A retrospective large database study.

Ariel Hammerman,Sari Greenberg-Dotan,Erez Battat,Haim Bitterman,Baruch Brenner

The "real life" impact of adding bevacizumab to first-line treatment of metastatic colorectal cancer: A retrospective large database study.

2017

Ariel Hammerman
Sari Greenberg-Dotan
Erez Battat
Haim Bitterman
Baruch Brenner

e14571 Background: Bevacizumab is included in the Israeli National List of Reimbursed Drugs (NLRD) for 1st line treatment of all metastatic colorectal cancer (mCRC) patients since 7/2006. This stud...

Keywords:

Physical therapy
Oncology
Bevacizumab
Colorectal cancer
Internal medicine
Medicine
database study
first line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations